Arcturus Therapeutics Inc., a San Diego life sciences company founded this year, secured $5 million in a Series A funding round led by multiple private investors from Canada, Japan and the U.S.
The funding, involving 90 percent of the seed investors, will enable the company to nominate is first clinical candidate next year, and recruit top talent to expand its operations at the Janssen Labs in La Jolla, the company said.
Arcturus said it is poised to become an industry leader in the application of RNAi technologies for the treatment of rare diseases.
— SDBJ Staff Report
- Advertisement -
